Corrigendum to “Safety and efficacy of semaglutide in post kidney transplants patients with type 2 diabetes or post-transplant diabetes” [J. Clin. Translat. Endoc. 36C (2024) 100343]

IF 4.2 Q1 ENDOCRINOLOGY & METABOLISM

Journal of Clinical and Translational Endocrinology Pub Date : 2024-12-01 DOI:10.1016/j.jcte.2024.100360

Moeber Mohammed Mahzari , Omar Buraykan Alluhayyan , Mahdi Hamad Almutairi , Mohammed Abdullah Bayounis , Yazeed Hasan Alrayani , Amir A. Omair , Awad Saad Alshahrani

引用次数: 0

查看原文本刊更多论文

semaglutide对肾移植后2型糖尿病或移植后糖尿病患者的安全性和疗效"[J. Clin. Translat. Endoc. 36C (2024) 100343]的更正

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Clinical and Translational Endocrinology ENDOCRINOLOGY & METABOLISM-

CiteScore

6.10

自引率

0.00%

发文量

审稿时长

16 weeks